Skip to main content

Table 1 Patient characteristics

From: Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Number of patients34
Median age (range)59 (29–79)
 Male25 (73.5%)
 Female9 (26.5%)
Clinical T stage
 T1–21 (2.9%)
 T3–433 (97.1%)
Clinical N stage
 N−3 (8.8%)
 N+31 (91.2%)
CEA (ng/mL)
 < 5.017 (50%)
 ≥ 5.017 (50%)
  1. N, lymph node; N+, lymph node positive; N−, lymph node negative; CEA, carcino-embryonic antigen